Atlas Trials

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Clinical trial NCT04354324 · UNKNOWN

Trial details

NCT number
NCT04354324
Sponsor
Zhujiang Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Papillary Thyroid Cancer
Start date
2020-04-20
Primary completion
2024-06-30
Enrollment
254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.